论文部分内容阅读
采用红细胞C_3b受体花环试验检测了28例子宫颈鳞癌患者(下称患者组)放疗前后红细胞免疫功能状态,并与正常对照组进行比较。结果:患者组放疗前后的红细胞C-3b受体花环率(RC_3bRR)均显著低于对照组.但放疗前后变化不大;Ⅱ期患者RC_3bRR显著高于Ⅲ期者(P<0.05)。认为C_3bRR可作为初步判断子宫颈鳞癌放疗疗效、辐射损伤及估计预后的一个指标,并可以指导放疗及过继免疫治疗。
The erythrocyte immune function status of 28 cases of cervical squamous cell carcinoma (hereinafter referred to as patient group) before and after radiotherapy was detected by the erythrocyte C_3b receptor rosette test and compared with the normal control group. Results: The R-C3bRR of patients before and after radiotherapy was significantly lower than that of the control group, but there was no significant change before and after radiotherapy. The RC3bRR of patients with stage II was significantly higher than that of patients with stage III (P <0.05). That C_3bRR cervical cancer as a preliminary assessment of radiotherapy efficacy, radiation injury and prognosis of an indicator, and can guide the radiotherapy and adoptive immunotherapy.